Sysmex UK LIMITED

Sysmex UK LIMITED, a for-profit organization headquartered in Milton Keynes, United Kingdom, supplies hematology and hemostasis diagnostic reagents, laboratory consumables, and maintenance services to U.S. military medical facilities as a prime contractor under full-and-open (non-set-aside) competition. The vendor operates exclusively as a prime, with no subcontract footprint in the federal portfolio.

Sysmex UK LIMITED's federal customer base is heavily concentrated in a single agency. The Department of the Air Force's United States Air Forces in Europe and Africa (USAFE-AFAFRICA) accounts for 95 of 123 total awards (77% of portfolio) and $3.5 million of $3.7 million combined potential value (95% of dollars). The Defense Health Agency places the remaining customer volume, with 20 awards valued at $86 thousand, and the Department of the Air Force Defense Finance and Accounting Service places 8 awards worth $45 thousand. The portfolio exhibits extreme customer concentration with no meaningful diversification.

The vendor's work is narrowly focused on medical laboratory supplies. Representative prime awards include a $10.2 million maintenance order from USAFE-AFAFRICA through September 2026 for Sysmex XN-2000 hematology analyzer upkeep at RAF Lakenheath (awarded September 2025), a $13.2 million reagent delivery from the Defense Health Agency for the 48th Medical Group in March 2025, and multiple monthly reagent and maintenance delivery orders averaging $1 thousand to $9 thousand each issued by USAFE-AFAFRICA and the Defense Health Agency between 2021 and April 2026. All awards are firm fixed-price delivery orders with no set-aside designation.

The vendor holds two active parent IDIQs. A single-award Indefinite Delivery Indefinite Quantity contract valued at $750 thousand and running through August 31, 2029 with USAFE-AFAFRICA (awarded September 2024) serves as the vehicle for the bulk of recent task orders to the 48th Medical Group. An earlier IDIQ valued at $1,421,012.73 and running from September 2020 through August 2024 generated the majority of awards in the 2021–2024 window. The three highest-volume parent vehicles are two legacy USAFE-AFAFRICA IDIQs (FA558720D0003 with 56 task orders totaling $199 thousand and FA558717D0003 with 38 task orders totaling $175 thousand) and the current USAFE-AFAFRICA IDIQ (FA558724D0004 with 22 task orders totaling $88 thousand).

Activity has declined modestly year over year, from 14–15 awards annually in 2022–2023 to 11 in 2025 and 6 in the first four months of 2026. Only one award ($10 thousand) faces completion within the next twenty-four months, indicating minimal near-term recompete exposure. The vendor's NAICS footprint is concentrated in drugs and druggists' sundries merchant wholesaling (57 awards) and analytical laboratory instrument manufacturing (39 awards). PSC coding reflects the narrow scope: in vitro diagnostic substances and reagents account for 72 awards, and laboratory equipment and supplies add 28 awards.